PHATHOM PHARMACEUTICALS

NJ

Biopharmaceutical company

Active 2021–2026. The register lists this client once for every firm that files on its behalf; all 2 of its records are shown together here.

Filings
19
Filed By
2
Reported In-House
—
Reported By Firms
$115,000

Filings

YearFirmPeriodAmountDoc
2026 JEFFREY J. KIMBELL & ASSOCIATES, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$15,000
2026 JEFFREY J. KIMBELL & ASSOCIATES, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$15,000
2026 JEFFREY J. KIMBELL & ASSOCIATES, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$15,000
2025 JEFFREY J. KIMBELL & ASSOCIATES, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$15,000
2025 JEFFREY J. KIMBELL & ASSOCIATES, INC. 3rd Quarter (July 1 - Sep 30)
3rd Quarter - Report
$15,000
2025 JEFFREY J. KIMBELL & ASSOCIATES, INC. 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Report
$15,000
2025 JEFFREY J. KIMBELL & ASSOCIATES, INC. 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report
$15,000
2025 JEFFREY J. KIMBELL & ASSOCIATES, INC. 1st Quarter (Jan 1 - Mar 31)
Registration
—
2023 ARNOLD & PORTER KAYE SCHOLER LLP 2nd Quarter (Apr 1 - June 30)
2nd Quarter - Termination (No Activity)
—
2023 ARNOLD & PORTER KAYE SCHOLER LLP 1st Quarter (Jan 1 - Mar 31)
1st Quarter - Report (No Activity)
—
Page 1 of 2  ·  19 filings Next
Filed By
Issue Areas
IssueActivities
Health Issues 12